VRTX Financing Cash Flow
Vertex Pharmaceuticals · Financing Cash Flow
VRTX Financing Cash Flow
Latest reported-$2.20Bperiod ending
VRTX Cash from Financing ($50.90M → -$2.20B)
Annual financing cash flow
High-resolution chart · PNG
VRTX financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -2,261,300,000 | |
| -1,494,900,000 | |
| -562,200,000 | |
| -67,700,000 | |
| -1,478,000,000 | |
| -505,281,000 | |
| 126,773,000 | |
| -71,219,000 | |
| 68,404,000 | |
| 133,271,000 | |
| 188,919,000 | |
| 497,376,000 | |
| 180,884,000 | |
| 172,204,000 | |
| -124,238,000 | |
| 425,057,000 | |
| 999,006,000 | |
| 620,738,000 | |
| -10,190,000 | |
| 365,865,000 | |
| 197,456,000 | |
| -8,626,000 | |
| 37,468,000 | |
| 13,842,000 | |
| -3,982,000 | |
| 544,031,000 | |
| 2,800,000 | |
| 4,200,000 | |
| 164,800,000 | |
| 87,100,000 | |
| 1,700,000 | |
| 71,900,000 | |
| 1,600,000 | |
| -1,200,000 | |
| 50,900,000 |